Publication:
EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry

dc.contributor.authorsGumus, M.; Ozkan, M.; Yilmaz, U.; Tekin, S. B.; Demir, C.; Erdogan, A.; Dane, F.
dc.date.accessioned2022-03-10T17:56:27Z
dc.date.accessioned2026-01-10T16:55:24Z
dc.date.available2022-03-10T17:56:27Z
dc.date.issued2017
dc.identifier.doidoiWOS:000463860801715
dc.identifier.eissn1556-1380
dc.identifier.issn1556-0864
dc.identifier.urihttps://hdl.handle.net/11424/221983
dc.identifier.wosWOS:000463860801715
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF THORACIC ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectnon-small cell lung cancer
dc.subjectErlotinib
dc.subjectEGFR mutation
dc.titleEGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS2142
oaire.citation.issue11
oaire.citation.startPageS2142
oaire.citation.titleJOURNAL OF THORACIC ONCOLOGY
oaire.citation.volume12

Files